SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-047191
Filing Date
2020-04-16
Accepted
2020-04-16 07:45:36
Documents
15
Period of Report
2020-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2015938-1_8k.htm   iXBRL 8-K 23858
2 EXHIBIT 99.1 tm2015938d1_ex99-1.htm EX-99.1 9128
6 GRAPHIC tm2015938-1_8kimg01.jpg GRAPHIC 6211
7 GRAPHIC tm2015938d1_ex99-1img001.jpg GRAPHIC 3094
  Complete submission text file 0001104659-20-047191.txt   229432

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amag-20200416.xsd EX-101.SCH 2465
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amag-20200416_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amag-20200416_pre.xml EX-101.PRE 22714
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2015938-1_8k_htm.xml XML 3502
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 20795210
SIC: 2834 Pharmaceutical Preparations